Sachan Mayank, Singh Nikhil Kumar, Naithani Bhavya, Abbas Haider, Dube Mallikarjun, Naithani Bhavini
Department of Anaesthesia, Critical Care and Pain, Apollomedics Superspeciality Hospital, Lucknow, Uttar Pradesh, India.
Department of Anaesthesia, Critical Care and Pain, Mahamana Pandit Madanmohan Malviya Cancer Centre, Homi Bhabha Cancer Hospital, Varanasi, Uttar Pradesh, India.
Natl J Maxillofac Surg. 2022 May-Aug;13(2):201-207. doi: 10.4103/njms.NJMS_208_20. Epub 2022 Jul 15.
The aim of the study is to compare intubating conditions and hemodynamic changes during awake fiber-optic intubation (AFOI) using midazolam and fentanyl versus dexmedetomidine in cases of difficult airway.
A randomized prospective study was conducted in the department of oral and maxillofacial surgery, with a total of 60 patients, 18-55 years of age, ASA class I-II, of either sex with anticipated difficult airway planned for elective surgery. They were divided into two groups; group I patients received 1 μg/kg of dexmedetomidine and then an infusion of 0.5 to 0.7 μg/kg/hr of dexmedetomidine, whereas group II patients received 1 μg/kg of intra-venous (iv) fentanyl and 0.05 mg/kg of iv midazolam with additional doses of 0.02 mg/kg to achieve a Ramsay Sedation Scale score of ≥2. The ease of placement of the fiber-optic scope and the endotracheal tube and the patient's reaction to placement of the fiber-optic scope were assessed on a scale of 1-4 and were recorded as endoscopist satisfaction score and patient discomfort score, respectively.
The endoscopy time ranged from 2.66 ± 1.00 (group I) to 3.90 ± 0.96 (group II) minutes and was found to be statistically significant (p < 0.05). Also, the patient discomfort score was recorded during endoscopy (1-4) and ranged from 1.3 ± 0.53 (group I) and 2.33 ± 0.66 (group II) and was found to be statistically significant (p value < 0.05). Patients undergoing the procedure who received dexmedetomidine were thus more comfortable than those who received fentanyl and midazolam combination.
Dexmedetomidine provided better intubating conditions, patient tolerance, higher endoscopist satisfaction, and reduced hemodynamic responses compared to fentanyl and midazolam combinations. Also, the major advantage of dexmeditomidine for preservation of airway with a lesser degree of respiratory depression allows for safer use of AFOI in cases of difficult airway.
本研究的目的是比较在困难气道病例中,使用咪达唑仑和芬太尼与右美托咪定进行清醒纤维支气管镜引导插管(AFOI)时的插管条件和血流动力学变化。
在口腔颌面外科进行了一项随机前瞻性研究,共有60例年龄在18 - 55岁、ASA分级为I - II级、计划进行择期手术且预计气道困难的患者,性别不限。他们被分为两组;I组患者接受1μg/kg的右美托咪定,然后以0.5至0.7μg/kg/小时的速度输注右美托咪定,而II组患者接受1μg/kg的静脉注射(iv)芬太尼和0.05mg/kg的iv咪达唑仑,并额外给予0.02mg/kg的剂量以达到Ramsay镇静评分≥2。根据1 - 4分的量表评估纤维支气管镜和气管导管放置的难易程度以及患者对纤维支气管镜放置的反应,并分别记录为内镜医师满意度评分和患者不适评分。
内镜检查时间范围为2.66±1.00(I组)至3.90±0.96(II组)分钟,差异具有统计学意义(p < 0.05)。此外,在内镜检查期间记录了患者不适评分(1 - 4),范围为1.3±0.53(I组)和2.33±0.66(II组),差异具有统计学意义(p值< 0.05)。因此,接受右美托咪定的患者在操作过程中比接受芬太尼和咪达唑仑联合用药的患者更舒适。
与芬太尼和咪达唑仑联合用药相比,右美托咪定提供了更好的插管条件、患者耐受性、更高的内镜医师满意度,并减少了血流动力学反应。此外,右美托咪定在保留气道方面的主要优势在于呼吸抑制程度较轻,这使得在困难气道病例中更安全地使用AFOI。